OHSU Cancer Institute researchers get closer to predict survivability for some cancer patientsJune 28, 2007PORTLAND, Ore.- Oregon Health & Science University Cancer Institute researchers have developed a Web-based software program that can help head and neck cancer patients better predict their survivability. "This new tool can help us make personalized predictions of conditional survival for an individual patient depending on his or her specific situation," said Sam Wang, M.D., Ph.D., principal investigator, Holman Pathway Resident in the Department of Radiation Medicine, OHSU School of Medicine. Conditional survival is a statistical system that takes into account the age when the patient was diagnosed with cancer and the time elapsed since diagnosis. The new Web-browser software tool, called the regression model, can calculate a patient's conditional survival based on the patient's age, gender, race and tumor site, stage and aggressiveness. The study was recently presented at the annual American Society of Clinical Oncologists. In a previous study researchers, including Wang, demonstrated the concept of conditional survival for head and neck cancer. They showed the longer patients survive after diagnosis and treatment, their better their prognosis. "This is the first time we have the ability to make a customized prediction of conditional survival probability for an individual head and neck cancer survivor, based on his or her specific characteristics," said Wang. The long-term goal is to build similar software tools for other cancers, Wang explained,so that physicians will be able to give cancer patients more individualized prognosis and treatment recommendations. "Now that cancer researchers are beginning to collect more specific information about patients' tumors, such as tumor markers and genetic information, there is increasing interest in the development of these types of tools for making more specific predictions of a patient's prognosis," Wang said. Oregon Health & Science University |
|||||||||||||||||||||
| Related Cancer Patients Current Events and Cancer Patients News Articles Approved lymphoma drug shows promise in early tests against bone cancer A drug already approved for the treatment of lymphoma may also slow the growth of the most deadly bone cancer in children and teens, according to an early-stage study published online today in the International Journal of Cancer. Chemo-radiation before prostate removal may prevent cancer recurrence Researchers in the Oregon Health & Science University Knight Cancer Institute and the Portland Veterans Affairs Medical Center have found a combination of radiation therapy and chemotherapy given before prostate removal is safe and may have the potential to reduce cancer recurrence and improve patient survival. Aiming to avoid damage to neurocognitive areas of the brain during cranial radiation Radiation oncologists at Rush University Medical Center are intent on finding ways to avoid damage to the critically important hippocampus and limbic circuit of the brain when cranial radiation is required to treat existing or potential metastatic cancers. Preventative brain radiation for lung cancer patients: Benefits and risks A new study is taking a closer look at the benefits versus risks for lung cancer patients to undergo preventative brain radiation therapy as a means to stop cancer from spreading to the brain. Short-term hormone therapy and intermediate dose radiation increases survivial for early stage prostate cancer Short-term hormone therapy given prior to and during intermediate dose radiation treatment for men with early stage prostate cancer increases their chance of living longer, compared to those who receive the same radiation alone. Early-stage, HER2-positive breast cancer patients at increased risk of recurrence Early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller are at significant risk of recurrence of their disease, compared to those with early-stage disease who do not express the aggressive protein, according to a study led by researchers at The University of Texas M. D. Anderson Cancer Center. Developmental drug may help bone fractures heal after radiation exposure A drug currently under development by the University of Pittsburgh School of Medicine may help bone fractures heal more quickly after radiation exposure, according to a study by Pitt researchers. Adapting Space-Industry Technology to Treat Breast Cancer Researchers at Rush University Medical Center and Argonne National Laboratory are collaborating on a study to determine if an imaging technique used by NASA to inspect the space shuttle can be used to predict tissue damage often experienced by breast cancer patients undergoing radiation therapy. Biofield therapies: helpful or full of hype? Biofield therapies, which claim to use subtle energy to stimulate the body's healing process, are promising complementary interventions for reducing the intensity of pain in a number of conditions, reducing anxiety for hospitalized patients and reducing agitated behaviors in dementia, over and above what standard treatments can achieve. Researchers use drug-radiation combo to eradicate lung cancer Researchers at UT Southwestern Medical Center have eliminated non-small cell lung (NSCL) cancer in mice by using an investigative drug called BEZ235 in combination with low-dose radiation. More Cancer Patients Current Events and Cancer Patients News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||